GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BrainCool AB (publ) BRAIN.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

1.06

-0.93%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About BrainCool AB (publ)

Its shares trade on Nasdaq Stockholm under the ticker BRAIN.ST. It has been listed since 7 May 2014. In the fiscal year to 31 December 2025, it reported revenue of SEK 36.2m and a net loss of SEK 37.0m. At that date it held total assets of SEK 192.4m and shareholders' equity of SEK 175.8m.

BrainCool AB engages in the development, marketing, and trade of medical cooling systems for the healthcare sector. The company is headquartered in Lund, Skane. The company went IPO on 2014-05-07. The company develops a medical device for therapeutic brain cooling. BrainCool publ AB uses a patented cooling method developed by Dignitana AB, the marker of the DigniCap System for the prevention of chemotherapy-related hair loss. The technology used in the BrainCool System allows cooling of the neck, which helps to speed perfusion and cooling of blood before it reaches the brain. The therapeutic hypothermia device is dedicated to patients suffering from stroke, cardiac arrest, traumatic brain injury or neonatal asphyxia. BrainCool publ AB is a wholly owned subsidiary of Dignitana AB.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
7 May 2014

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • BrainCool AB develops medical cooling systems for healthcare sector
  • The company uses a patented cooling method developed by Dignitana AB
  • The BrainCool System enables neck cooling to speed blood perfusion and brain cooling

Weaknesses

  • BrainCool AB is a wholly owned subsidiary of Dignitana AB
  • The company's technology is used for specific medical conditions like stroke and cardiac arrest
  • The company's IPO was in 2014

Opportunities

  • The company's medical cooling systems target conditions such as stroke and neonatal asphyxia
  • The DigniCap System prevents chemotherapy-related hair loss
  • The company's technology allows cooling of blood before it reaches the brain

Threats

  • The company's technology is limited to specific medical applications
  • The company's subsidiary status may affect independence
  • The company's IPO date is 2014 which may indicate limited recent market presence

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.